Effect of angiotensin II on proliferation and differentiation of mouse induced pluripotent stem cells into mesodermal progenitor cells

Biochemical and Biophysical Research Communications

Volumn 420, Issue 1, 2012, Pages 148-155

  Ishizuka, Toshiaki ^a   Goshima, Hazuki ^a   Ozawa, Ayako ^a   Watanabe, Yasuhiro ^a  

^a NATIONAL DEFENSE MEDICAL COLLEGE   (Japan)

Author keywords

Angiotensin II; Induced pluripotent stem cells; P38 MAPK; Superoxide

Indexed keywords

4 (4 FLUOROPHENYL) 2 (4 METHYLSULFINYLPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; ANGIOTENSIN II; ANGIOTENSIN RECEPTOR; ANGIOTENSIN RECEPTOR ANTAGONIST; CANDESARTAN; COLLAGEN TYPE 4; DNA; JANUS KINASE; LEUKEMIA INHIBITORY FACTOR; MITOGEN ACTIVATED PROTEIN KINASE INHIBITOR; SCAVENGER; STAT3 PROTEIN; TEMPOL; VASCULOTROPIN RECEPTOR 2;

ANIMAL CELL; ARTICLE; CELL CULTURE; CELL DIFFERENTIATION; CELL PROLIFERATION; CELL STIMULATION; CONTROLLED STUDY; DNA SYNTHESIS; ENZYME ACTIVATION; ENZYME INHIBITION; MESODERM; MESODERM STEM CELL; MOUSE; NONHUMAN; PLURIPOTENT STEM CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; STEM CELL;

ANGIOTENSIN II; ANGIOTENSIN RECEPTOR ANTAGONISTS; ANIMALS; BENZIMIDAZOLES; CELL DIFFERENTIATION; CELL PROLIFERATION; CELLS, CULTURED; CULTURE MEDIA; CYCLIC N-OXIDES; DNA; INDUCED PLURIPOTENT STEM CELLS; JANUS KINASES; LEUKEMIA INHIBITORY FACTOR; MESODERM; MICE; P38 MITOGEN-ACTIVATED PROTEIN KINASES; RECEPTOR, ANGIOTENSIN, TYPE 1; SPIN LABELS; STAT3 TRANSCRIPTION FACTOR; STEM CELLS; TETRAZOLES;

IPS;

EID: 84859105954     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2012.02.132     Document Type: Article

References (22)

1. Wang Z., Rao P.J., Shillcutt S.D., Newman W.H. Angiotensin II induces proliferation of human cerebral artery smooth muscle cells through a basic fibroblast growth factor dependent mechanism. Neuroscience Letters 2005, 373:38-41.
2. Marshall R.P., McAnulty R.J., Laurent G.J. Angiotensin II is mitogenic for human lung fibroblasts via activation of the type 1 receptor. American Journal of Respiratory and Critical Care Medicine 2000, 161:1999-2004.
3. Zhang A., Ding G., Huang S., Wu Y., Pan X., Guan X., Chen R., Yang T. C-Jun NH2-terminal kinase mediation of angiotensin II-induced proliferation of human mesangial cells. American Journal of Physiology Renal Physiology 2005, 288:F1118-F1124.
4. Rodgers K.E., Xiong S., Steer R., diZerega G.S. Effect of angiotensin II on hematopoietic progenitor cell proliferation. Stem Cells 2000, 18:287-294.
5. 2+/PKC as well as EGF receptor- dependent PI3K/Akt/mTOR/p70S6K1 signal pathways in mouse embryonic stem cells. Journal of Cellular Physiology 2007, 211:618-629.
6. Zambidis E.T., Park T.S., Yu W., Tam A., Levine M., Yuan X., Pryzhkova M., Peault B. Expression of angiotensin- converting enzyme (CD143) identifies and regulates primitive hemangioblasts derived from human pluripotent stem cells. Blood 2008, 112:3601-3614.
7. Kim Y.M., Jeon E.S., Kim W.R., Jho S.K., Ryu S.W., Kim J.H. Angiotensin II-induced differentiation of adipose tissue-derived mesenchymal stem cells to smooth muscle-like cells. International Journal of Biochemistry and Cell Biology 2008, 40:2482-2491.
8. Takahashi K., Yamanaka S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 2006, 126:663-676.
9. Okita K., Ichisaka T., Yamanaka S. Generation of germline-competent induced pluripotent stem cells. Nature 2007, 448:313-317.
10. Narazaki G., Uosaki H., Teranishi M., Okita K., Kim B., Matsuoka S., Yamanaka S., Yamashita J.K. Directed and systematic differentiation of cardiovascular cells from mouse induced pluripotent stem cells. Circulation 2008, 118:498-506.
11. Schenke-Layland K., Rhodes K.E., Angelis E., Butylkova Y., Heydarkhan-Hagvall S., Gekas C., Zhang R., Goldhaber J.I., Mikkola H.K., Plath K., MacLellan W.R. Reprogramming mouse fibroblasts differentiate into cells of the cardio vascular and hematopoietic lineages. Stem Cells 2008, 26:1537-1546.
12. Griendling K.K., Mimeri C.A., Ollerenshaw J.D., Alexander R.W. Angiotensin II stimulates NADH and NADPH oxidase activity in cultured vascular smooth muscle cells. Circulation Research 1994, 74:1141-1148.
13. Chan E.C., Jiang F., Peshavariya H.M., Dusting G.J. Regulation of cell proliferation by NADPH oxidase-mediated signaling potential roles in tissue repair, regenerative medicine and tissue engineering. Pharmacology and Therapy 2009, 122:97-108.
14. Kristensen D.M., Kalisz M., Nielsen J.H. Cytokine signaling in embryonic stem cells. Acta Pathologica Microbiologica et Immunologica Scandinavica 2005, 113:756-772.
15. Marreno M.B., Schieffer B., Paxton W.G., Heerdt L., Berk B.C., Delafontaine P., Hernstein K.H. The angiotensin II type 1 receptor associates with and stimulates JAK2 in rat aortic smooth muscle cells. Nature 1995, 375:247-250.
16. Marreno M.B., Schieffer B., Harp J.B., Ling B. Role of Janus kinases/signal transducer and activator of transcription and mitogen-activated protein kinase cascades in angiotensin II- and platelet-derived growth factor-induced vascular smooth muscle proliferation. Journal of Biological Chemistry 1997, 272:24684-24690.
17. Simon A.R., Rai U., Fanburg B.L., Cochran B.H. Activation of the JAK-STAT pathway by reactive oxygen species. American Journal of Physiology 1998, 275:C1640-C1652.
18. Schieffer B., Luchtefeld M., Braun S., Hilfiker A., Hilfiker-Kleiner D., Drexler H. Role of NADPH oxidase in angiotensin II-induced JAK/STAT signaling and cytokine induction. Circulation Research 2000, 87:1195-1201.
19. Barruet E., Hadadeh Q., Peireti F., Renault V.W., Hadial Y., Bernot D., Toumaire R., Negre D., Juhan-Vague I., Alessi M.C., Binetruy B. P38 mitogen activated protein kinase controls two-successive-steps during the early mesodermal commitment of embryonic stem cells. Stem Cells and Development 2011, 20:1233-1246.
20. Wu J., Kubota J., Hirayama J., Nagai Y., Nishina S., Yokoi T., Asaoka Y., Seo J., Shimizu N., Kaiho H., Watanabe T., Azuma N., Katada T., Nishina H. P38 mitogen-activated protein kinase controls a switch between cardiomyocyte and neuronal commitment of murine embryonic stem cells by activating myocyte enhancer factor 2C-dependent bone morphogenetic protein 2 transcription. Stem Cells and Development 2010, 19:1723-1734.
21. Grady E.F., Seci I.A., Griffin C.A., Schambelam M., Karynyak J.E. Expression of AT2 receptors in the developing rat fetus. Journal of Clinical Investigation 1991, 88:921-933.
22. Rodriguez-Pallares J., Quiroz C.R., Parga J.A., Guerra M.J., Labandeira-Garcia J.L. Angiotensin II increases differentiation of dopaminergic neurons from mesencephalic precursors via angiotensin type 2 receptors. European Journal of Neuroscience 2004, 20:1489-1498.